Hypersensitivity of myofilament response to Ca2+ in association with maladaptation of estrogen-deficient heart under diabetes complication

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 292, Issue 2, 2007, Pages

  Thawornkaiwong, Ariyaporn ^a   Pantharanontaga, Jantarima ^a   Wattanapermpool, Jonggonnee ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

1 adrenergic receptor; Heart; Heat shock protein 72; Insulin

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (MAGNESIUM); BETA 1 ADRENERGIC RECEPTOR; CALCIUM; ESTROGEN; HEAT SHOCK PROTEIN 72; INSULIN; MYOSIN HEAVY CHAIN ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CONTROLLED STUDY; DIABETES MELLITUS; ESTROGEN DEFICIENCY; FEMALE; HEART; HEART PROTECTION; HYPERSENSITIVITY; IMMUNOBLOTTING; MALADJUSTMENT; MYOFILAMENT; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PUBLICATION; RAT; RECEPTOR BINDING; SEX DIFFERENCE; SUPPLEMENTATION;

ACTOMYOSIN; ADENOSINE TRIPHOSPHATASES; ANIMALS; BODY WEIGHT; CALCIUM; DIABETES MELLITUS, EXPERIMENTAL; ESTRADIOL; ESTROGENS; FEMALE; HEART; HSP72 HEAT-SHOCK PROTEINS; HYPOGLYCEMIC AGENTS; IMMUNOBLOTTING; INSULIN; KINETICS; MICROFILAMENTS; MYOFIBRILS; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; SARCOLEMMA; UTERUS;

EID: 33846817381     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00365.2006     Document Type: Article

References (44)

1. Atalay M, Oksala NKJ, Laaksonen DE, Khanna S, Nakao C, Lappalainen J, Roy S, Hänninen O, Sen CK. Exercise training modulates heat shock protein response in diabetic rats. J Appl Physiol 97: 605-611, 2004.
2. Baker SP, Potter LT. Purification and partial characterization of cardiac plasma membranes rich in β-adrenoreceptors. Membr Biochem 3: 185-205, 1980.
3. Benjamin IJ, McMillan DR. Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. Circ Res 83: 117-132, 1998.
4. Bers DM. Cardiac excitation-contraction coupling. Nature 415: 198-205, 2002.
5. 1-adrenergic receptor in transgenic mice. J Mol Cell Cardiol 32: 817-830, 2000.
6. Bristow MR. β-Adrenergic receptor blockade in chronic heart failure. Circulation 101: 558-569, 2000.
7. Bristow MR, Minobe W, Rasmussen R, Larrabee P, Skerl L, Klein JW, Anderson FL, Murray J, Mestroni L, Karwande SV, Fowler M, Ginsburg R. β-Adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J Clin Invest 89: 803-815, 1992.
8. Bupha-Intr T, Wattanapermpool J. Cardioprotective effects of exercise training on myofilament calcium activation in ovariectomized rats. J Appl Physiol 96: 1755-1760, 2004.
9. Bupha-Intr T, Wattanapermpool J. Regulatory role of ovarian sex hormones in calcium uptake activity of cardiac sarcoplasmic reticulum. Am J Physiol Heart Circ Physiol 291: H1101-H1108, 2006.
10. Carter SG, Karl DW. Inorganic phosphate assay with malachite green: an improvement and evaluation. J Biochem Biophys Methods 7: 7-13, 1982.
11. Chakraborti S, Chakraborti T, Shaw G. β-Adrenergic mechanisms in cardiac diseases: a perspective. Cell Signal 12: 499-513, 2000.
12. 1-adrenergic receptor transgenic mice. Proc Natl Acad Sci USA 96: 7059-7064, 1999.
13. Fabiato A. Computer programs for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands. Methods Enzymol 157: 378-417, 1988.
14. Fukuharu M, Sato J, Ohsawa I, Oshida Y, Nagasaki M, Nakai N, Shimomura Y, Hattori M, Tokudome S, Sato Y. Additive effects of estrogen deficiency and diabetes on bone mineral density in rats. Diabetes Res Clin Pract 48: 1-8, 2000.
15. Ganguly PK, Beamish RE, Dhalla KS, Innes IR, Dhalla NS. Norepinephrine storage, distribution, and release in diabetic cardiomyopathy. Am J Physiol Endocrinol Metab 252: E734-E739, 1987.
16. Gomes AV, Potter JD. Molecular and cellular aspects of troponin cardiomyopathies. Ann NY Acad Sci 1015: 214-224, 2004.
17. Grohé C, Kahlert S, Löbbert K, Stimpel M, Karas RH, Vetter H, Neyses L. Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett 416: 107-112, 1997.
18. Gustafsson I, Brendorp B, Seibaek M, Burchardt H, Hildebrandt P, Køber L, and Torp-Pedersen C. Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. J Am Coll Cardiol 43: 771-777, 2004.
19. 2+ sensitivity of cardiac muscle contraction. J Biol Chem 279: 14488-14495, 2004.
20. 2+ sensitivity of cardiomyopathic hamster hearts. Pflugers Arch 429: 539-545, 1995.
21. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112: e154-e235, 2005.
22. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34: 29-34, 1974.
23. Kass DA, Solaro RJ. Mechanisms and use of calcium-sensitizing agents in the failing heart. Circulation 113: 305-315, 2006.
24. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 26: 1257-1263, 1995.
25. Knowlton AA, Sun L. Heat-shock factor-1, steroid hormones, and regulation of heat-shock protein expression in the heart. Am J Physiol Heart Circ Physiol 280: H455-H464, 2001.
26. 2+ affinity of cardiac thin filaments reconstituted with cardiomyopathy-related mutant cardiac troponin I. J Biol Chem 281: 13471-13477, 2006.
27. Lechat P, Packer M, Chalon S, Cucherat M, Arab T, Boissel JP. Clinical effects of β-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation 98: 1184-1191, 1998.
28. Lefkowitz RJ, Rockman HA, Koch WJ. Catecholamines, cardiac β-adrenergic receptors, and heart failure. Circulation 101: 1634-1637, 2000.
29. Mankhey RW, Bhatti F, Maric C. 17β-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy. Am J Physiol Renal Physiol 288: F399-F405, 2005.
30. 2+ activation and tension cost in myofialments from mouse hearts ectopically expressing enteric γ-actin. Am J Physiol Heart Circ Physiol 283: H642-H649, 2002.
31. Packer M, Coats AJS, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, DeMets DL. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344: 1651-1658, 2001.
32. Pagani ED, Solaro RJ. Method for measuring functional properties of sarcoplasmic reticulum and myofibrils in small samples of myocardium. In: Methods in Pharmacology, edited by Schwartz A. New York: Plenum, 1984, vol. 5, p. 44-61.
33. Post SR, Hammond HK, Insel PA. β-Adrenergic receptors and receptor signaling in heart failure. Annu Rev Pharmacol Toxicol 39: 343-360, 1999.
34. Ren J, Hintz KK, Roughead ZKF, Duan J, Colligan PB, Ren BH, Lee KJ, Zeng H. Impact of estrogen replacement on ventricular myocyte contractile function and protein kinase B/Akt activation. Am J Physiol Heart Circ Physiol 284: H1800-H1807, 2003.
35. Rice JJ, de Tombe PP. Approaches to modeling crossbridges and calcium-dependent activation in cardiac muscle. Prog Biophys Mol Biol 85: 179-195, 2004.
36. Sowers JR. Diabetes mellitus and cardiovascular disease in women. Arch Intern Med 158: 617-621, 1998.
37. 1-adrenergic receptors in ovariectomized rat hearts. Life Sci 72: 1813-1824, 2003.
38. Velloso LA, Carvalho CRO, Rojas FA, Folli F, Saad MJA. Insulin signalling in heart involves insulin receptor substrates-1 and -2, activation of phosphatidylinositol 3-kinase and the JAK 2-growth related pathway. Cardiovasc Res 40: 96-102, 1998.
39. Voss MR, Stallone JN, Li M, Cornelussen RNM, Knuefermann P, Knowlton AA. Gender differences in the expression of heat shock proteins: the effect of estrogen. Am J Physiol Heart Circ Physiol 285: H687-H692, 2003.
40. Wattanapermpool J. Increase in calcium responsiveness of cardiac myofilament activation in ovariectomized rats. Life Sci 63: 955-964, 1998.
41. Wattanapermpool J, Reiser PJ. Differential effects of ovariectomy on calcium activation of cardiac and soleus myofilaments. Am J Physiol Heart Circ Physiol 277: H467-H473, 1999.
42. Wolff MR, Buck SH, Stoker SW, Greaser ML, Mentzer RM. Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered β-adrenergically mediated protein phosphorylation. J Clin Invest 98: 167-176, 1996.
43. Wolff MR, Whitesell LF, Moss RL. Calcium sensitivity of isometric tension is increased in canine experimental heart failure. Circ Res 76: 781-789, 1995.
44. Yu HP, Shimizu T, Choudhry MA, Hsieh YC, Suzuki T, Bland KI, Chaudry IH. Mechanism of cardioprotection following trauma-hemorrhagic shock by a selective estrogen receptor-β agonist: up-regulation of cardiac heat shock factor-1 and heat shock proteins. J Mol Cell Cardiol 40: 185-194, 2006.